Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Katia Mancuso"'
Autor:
Marina Martello, Michele Cavo, Enrica Borsi, Silvia Armuzzi, Andrea Poletti, Ignazia Pistis, Vincenza Solli, Katia Mancuso, Barbara Taurisano, Lucia Pantani, Elena Zamagni, Carolina Terragna, Serena Rocchi, Paola Tacchetti, Ilaria Vigliotta, Gaia Mazzocchetti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S4-S5
Introduction Multiple Myeloma (MM) is a genetically complex disease, characterized by the recurrence of several chromosomal aberrations, which impair the disease prognosis. The use of genome-wide technologies has recently highlighted the existence of
Autor:
Barbara Taurisano, Marina Martello, Carolina Terragna, Lucia Pantani, Ilaria Vigliotta, Ilaria Rizzello, Vincenza Solli, Enrica Borsi, Silvia Armuzzi, Andrea Poletti, Katia Mancuso, Serena Rocchi, Ignazia Pistis, Paola Tacchetti, Elena Zamagni, Gaia Mazzocchetti, Michele Cavo
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S37
Background Multiple Myeloma (MM) is a plasma cell (PC) disorder characterized by the presence of multiple lytic lesions at the time of diagnosis. Recently, cell-free DNA (cfDNA) has proven to resume the heterogeneity of spatially distributed clones.
Autor:
Mauro Procacci, Nicoletta Testoni, Katia Mancuso, Marina Martello, Elena Zamagni, Enrica Borsi, Annalisa Pezzi, Lucia Pantani, Daniel Remondini, Carolina Terragna, Serena Rocchi, Beatrice Anna Zannetti, Barbara Santacroce, Giulia Marzocchi, Michele Cavo, Flores Dico, Paola Tacchetti, Giovanni Martinelli
Publikováno v:
Leukemia. 30:1869-1876
Hyperactivation of the Hedgehog (Hh) pathway, which controls refueling of multiple myeloma (MM) clones, might be critical to disease recurrence. Although several studies suggest the Hh pathway is activated in CD138- immature cells, differentiated CD1
Autor:
Paolo Spinnato, Eugenio Salizzoni, Katia Mancuso, Michele Cavo, Cristina Nanni, Alberto Bazzocchi, Elena Zamagni, Giacomo Filonzi, Stefano Fanti
Publikováno v:
AJR. American journal of roentgenology. 209(1)
The objective of this study is to compare the most recent systems for the staging of multiple myeloma (MM), the Durie-Salmon PLUS system and the International Staging System, according to patients' survival rates and response to therapy. Another obje
Autor:
Paola Tacchetti, Carolina Terragna, Lucia Pantani, Elena Zamagni, Katia Mancuso, Marina Martello, Michele Cavo, Annamaria Brioli, Ilaria Rizzello, Beatrice Anna Zannetti, Serena Rocchi
Despite significant improvement in outcomes have been observed for multiple myeloma (MM) patients over the past 10-15years, mainly due to the introduction of novel agents targeting the tumor clone and the bone marrow microenvironment, treatment of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec67c0084e50d1480781b1d25356179f
http://hdl.handle.net/11585/528891
http://hdl.handle.net/11585/528891
Autor:
Mauro Procacci, Enrica Borsi, Daniel Remondini, Paola Tacchetti, Giovanni Martinelli, Serena Rocchi, Marina Martello, Elena Zamagni, Carolina Terragna, Beatrice Anna Zannetti, Barbara Santacroce, Lucia Pantani, Giulia Marzocchi, Katia Mancuso, Michele Cavo, Angela Flores Dico, Annalisa Pezzi
Publikováno v:
Cancer Research. 76:3189-3189
The iperactivation of Hedgehog (Hh) pathway, which controls the refuel of the tumor clone, might be critical to Multiple Myeloma (MM) recurrence. In order to dissect the role played by Hh pathway in different MM cells compartments, and to evaluate it
Autor:
Daniel Remondini, Lucia Pantani, Gaia Ameli, Carolina Terragna, Serena Rocchi, Annalisa Pezzi, Giovanni Martinelli, Giulia Marzocchi, Marina Martello, Angela Flores Dico, Nicoletta Testoni, Paola Tacchetti, Anna Beatrice Zannetti, Enrica Borsi, Elena Zamagni, Michele Cavo, Katia Mancuso, Annamaria Brioli, Barbara Santacroce
Publikováno v:
ResearcherID
Background Although remarkable advances have been achieved in MM therapy, mainly thanks to the introduction of novel-agent-based regimens, the disease remains incurable. Neoplastic CD138+ plasma cells are the hallmark of MM: both their expansion in t
Autor:
Michele Cavo, Annamaria Brioli, Enrica Borsi, Paola Tacchetti, Elena Zamagni, Marina Martello, Viviana Guadagnuolo, Carolina Terragna, Katia Mancuso, Lucia Pantani, Flores Dico, Beatrice Anna Zannetti, Serena Rocchi, Giovanni Martinelli
Publikováno v:
Cancer Research. 74:3884-3884
Background Although the advances in Multiple Myeloma (MM) therapy, the disease remains incurable. The existence of Myeloma Propagating Cells (MPCs) is supposed to be one of the major causes of MM drug-resistance, leading to relapse. However, very lit
Autor:
Elena Zamagni, Carolina Terragna, Katia Mancuso, Paola Tacchetti, Beatrice Anna Zannetti, Marina Martello, Enrica Borsi, Giovanni Martinelli, Michele Cavo, Lucia Pantani, Flores Dico
Publikováno v:
Cancer Research. 73:3749-3749
Background Although the advances in Multiple Myeloma (MM) therapy, the disease remains incurable. The existence of Myeloma Propagating Cells (MPCs) is supposed to be one of the major causes of MM drug-resistance, leading to relapse. However, very lit
Autor:
Elena Zamagni, Cristina Nanni, Francesca Gay, Annalisa Pezzi, Marilena Bellò, Ilaria Rambaldi, Paola Tacchetti, Annamaria Brioli, Lucia Pantani, Valeria Magarotto, Beatrice Anna Zannetti, Massimo Menga, Giulia Marzocchi, Carolina Terragna, Katia Mancuso, Antonio Palumbo, Stefano Fanti, Michele Cavo
Publikováno v:
ResearcherID
Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder whose risk of progression to symptomatic MM (MM) is highly variable. Therefore, the identification of predictors of progression into MM is a relevant end point. Several markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e98109c497726d6d1835e16aee5d9bf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243505157&KeyUID=WOS:000349243505157
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243505157&KeyUID=WOS:000349243505157